Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
611 Comparison of nebulised dexmedetomidine,
ketamine, or midazolam for premedication in
preschool children undergoing bone marrow biopsy 		Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2018
612 Cardiac toxicity of hypofractionated radiotherapy in left breast cancer Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
613 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
614 Does Simple Oral Route of Administration Affect Acute Post Operative Pain?(Oral Pregabalin Versus Oral Morphine Sulphate) for Acute Post Operative Pain following Cancer Surgeries Department of Anesthesia, Intensive care and Pain management Dr. Alaa Mohammad El-Zohary 2018
615 Secondary signs of ligamentum teres injuries. A non-arthrographic and arthrographic MR findings correlation Department of Radiology Prof. Amro Farouk ِAhmedMourad 2018
616 Effect of Dexmedetomidine Added to Modified Pectoral Block on Postoperative Pain and Stress
Response in Patient Undergoing Modified Radical Mastectomy 		Department of Anesthesia, Intensive care and Pain management Dr. Montaser Abdel-Fattah Mohamed Mustafa 2018
617 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2018
618 Clinicopathologic Characteristics of Colorectal Polyps: A Study from South Egypt Cancer Institute Department of Pathology Israa Mostafa Kamal Mohammed 2018
619 New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2018
620 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018